Consumers increasingly prioritize natural health solutions that combine efficacy with convenient delivery formats. In response to this trend, Sirio developed three gummies with clinically researched macrobiotic strains, which the company will launch at next week’s CPHI 2024 trade show (October 8–10). The range includes GummiBiotics Defense to help support immune health, GummiBiotics IBS Ease to alleviate irritable bowel syndrome (IBS) symptoms and GummiBiotics Lean to aid in abdominal fat burning.
